Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  recombinant human interleukin-15
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Recombinant Human Interleukin-15 and Donor Natural Killer Cell Infusion in Treating Patients with Refractory or Relapsed Acute Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 2014LS092, NCI-2015-00396, P9880, 9880, NCT02395822
Recombinant Interleukin-15 in Treating Patients with Metastatic Melanoma or Kidney Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 85
Trial IDs: 10-C-0021, NCI-2015-00085, 100021, 10-C-0021 G, 9850, NCT01021059
Recombinant Interleukin-15 in Treating Patients with Cancer That is Metastatic or Cannot Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0113, NCI-2013-01520, 120113, P11905, NCT01572493
Recombinant Interleukin-15 in Treating Patients with Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN11-02, NCI-2012-02205, NCT01727076
Start Over